Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.

EQL Pharma

Ylin-
Alin-
Vaihto-
2027 Q1 -tulosraportti
17 päivää sitten

Tarjoustasot

Ei dataa

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2027 Q2 -tulosraportti
5.11.
Menneet tapahtumat
2027 Q1 -tulosraportti
7.8.
2026 Q4 -tulosraportti
8.5.
2026 Q3 -tulosraportti
4.2.
2026 Q2 -tulosraportti
5.11.2025
2026 Q1 -tulosraportti
8.8.2025

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 11.8.
    ·
    This is a company with a solid business that should be able to develop for many years to come. I see the share price slowly working its way up again after somewhat exaggerated reactions. 23kr right now. However, slightly disappointed even after the latest published CEO interview. Deliveries have faltered for a year now, and measures are still needed to get back in balance. "Secure processes". Goods are missing while, at the other end, parts of the inventory must be discarded. Lack of control and follow-up. Many ongoing wrong decisions. At the same time, launches are also being postponed. Partly because they are "complicated" products, but also because financing and liquidity are insufficient. I.e., "saving" their way to better balance. Questionable strategy, but under duress…… If this company could credibly demonstrate that it is now characterized by "order and tidiness" (recruitments/reinforcements have indeed taken place), I would gladly participate in a capital injection/new share issue that strengthens the balance sheet, ensures delivery reliability, and increases the pace of launches. It's difficult to fairly evaluate the management remotely, but I note that the past year has been more reactive than proactive. An aggressive new share issue that allows the company to quickly return to perhaps 25-30% growth and with clear economies of scale. It shouldn't be impossible to find two or three hundred million (or whatever is now required…) among existing shareholders. Perhaps with support from a couple of new interested parties. This company should be able to become a "money machine" in the future. All prerequisites are there. A future gold nugget. Will we be there in six months? Or will new complications arise?
    12.8.
    ·
    Yes. I'm possibly a bit jaded after forecast adjustments have typically been downwards over the past year. I do think the CEO's signals about remaining uncertainties were a bit ominous I haven't fully regained optimism:) And sure. Hospital products in Finland are outside the generic segment. But still a significant impact on results. Where I previously believed in a stable complementary pillar. . Based on the company's earlier description. Oh well. Patience is a virtue. We hold on to the words that everything (difficulties) has an end.
  • 7.8.
    ·
    ROTTEN!
  • 7.8.
    ·
    Not exactly a great report.
    7.8.
    ·
    Needs a CEO change in the company ...
  • 22.5.
    ·
    Why is it up?
    25.5.
    ·
    Because their concept is intact and their setbacks are of a one-off nature, everyone who can project 1 year ahead sees that the stock is worth buying.
  • 9.5.
    ·
    Things are not going well for AXEL, does he still have the confidence of the market and management?
    No
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

2027 Q1 -tulosraportti
17 päivää sitten

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 11.8.
    ·
    This is a company with a solid business that should be able to develop for many years to come. I see the share price slowly working its way up again after somewhat exaggerated reactions. 23kr right now. However, slightly disappointed even after the latest published CEO interview. Deliveries have faltered for a year now, and measures are still needed to get back in balance. "Secure processes". Goods are missing while, at the other end, parts of the inventory must be discarded. Lack of control and follow-up. Many ongoing wrong decisions. At the same time, launches are also being postponed. Partly because they are "complicated" products, but also because financing and liquidity are insufficient. I.e., "saving" their way to better balance. Questionable strategy, but under duress…… If this company could credibly demonstrate that it is now characterized by "order and tidiness" (recruitments/reinforcements have indeed taken place), I would gladly participate in a capital injection/new share issue that strengthens the balance sheet, ensures delivery reliability, and increases the pace of launches. It's difficult to fairly evaluate the management remotely, but I note that the past year has been more reactive than proactive. An aggressive new share issue that allows the company to quickly return to perhaps 25-30% growth and with clear economies of scale. It shouldn't be impossible to find two or three hundred million (or whatever is now required…) among existing shareholders. Perhaps with support from a couple of new interested parties. This company should be able to become a "money machine" in the future. All prerequisites are there. A future gold nugget. Will we be there in six months? Or will new complications arise?
    12.8.
    ·
    Yes. I'm possibly a bit jaded after forecast adjustments have typically been downwards over the past year. I do think the CEO's signals about remaining uncertainties were a bit ominous I haven't fully regained optimism:) And sure. Hospital products in Finland are outside the generic segment. But still a significant impact on results. Where I previously believed in a stable complementary pillar. . Based on the company's earlier description. Oh well. Patience is a virtue. We hold on to the words that everything (difficulties) has an end.
  • 7.8.
    ·
    ROTTEN!
  • 7.8.
    ·
    Not exactly a great report.
    7.8.
    ·
    Needs a CEO change in the company ...
  • 22.5.
    ·
    Why is it up?
    25.5.
    ·
    Because their concept is intact and their setbacks are of a one-off nature, everyone who can project 1 year ahead sees that the stock is worth buying.
  • 9.5.
    ·
    Things are not going well for AXEL, does he still have the confidence of the market and management?
    No
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

Ei dataa

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2027 Q2 -tulosraportti
5.11.
Menneet tapahtumat
2027 Q1 -tulosraportti
7.8.
2026 Q4 -tulosraportti
8.5.
2026 Q3 -tulosraportti
4.2.
2026 Q2 -tulosraportti
5.11.2025
2026 Q1 -tulosraportti
8.8.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

2027 Q1 -tulosraportti
17 päivää sitten

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2027 Q2 -tulosraportti
5.11.
Menneet tapahtumat
2027 Q1 -tulosraportti
7.8.
2026 Q4 -tulosraportti
8.5.
2026 Q3 -tulosraportti
4.2.
2026 Q2 -tulosraportti
5.11.2025
2026 Q1 -tulosraportti
8.8.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 11.8.
    ·
    This is a company with a solid business that should be able to develop for many years to come. I see the share price slowly working its way up again after somewhat exaggerated reactions. 23kr right now. However, slightly disappointed even after the latest published CEO interview. Deliveries have faltered for a year now, and measures are still needed to get back in balance. "Secure processes". Goods are missing while, at the other end, parts of the inventory must be discarded. Lack of control and follow-up. Many ongoing wrong decisions. At the same time, launches are also being postponed. Partly because they are "complicated" products, but also because financing and liquidity are insufficient. I.e., "saving" their way to better balance. Questionable strategy, but under duress…… If this company could credibly demonstrate that it is now characterized by "order and tidiness" (recruitments/reinforcements have indeed taken place), I would gladly participate in a capital injection/new share issue that strengthens the balance sheet, ensures delivery reliability, and increases the pace of launches. It's difficult to fairly evaluate the management remotely, but I note that the past year has been more reactive than proactive. An aggressive new share issue that allows the company to quickly return to perhaps 25-30% growth and with clear economies of scale. It shouldn't be impossible to find two or three hundred million (or whatever is now required…) among existing shareholders. Perhaps with support from a couple of new interested parties. This company should be able to become a "money machine" in the future. All prerequisites are there. A future gold nugget. Will we be there in six months? Or will new complications arise?
    12.8.
    ·
    Yes. I'm possibly a bit jaded after forecast adjustments have typically been downwards over the past year. I do think the CEO's signals about remaining uncertainties were a bit ominous I haven't fully regained optimism:) And sure. Hospital products in Finland are outside the generic segment. But still a significant impact on results. Where I previously believed in a stable complementary pillar. . Based on the company's earlier description. Oh well. Patience is a virtue. We hold on to the words that everything (difficulties) has an end.
  • 7.8.
    ·
    ROTTEN!
  • 7.8.
    ·
    Not exactly a great report.
    7.8.
    ·
    Needs a CEO change in the company ...
  • 22.5.
    ·
    Why is it up?
    25.5.
    ·
    Because their concept is intact and their setbacks are of a one-off nature, everyone who can project 1 year ahead sees that the stock is worth buying.
  • 9.5.
    ·
    Things are not going well for AXEL, does he still have the confidence of the market and management?
    No
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

Ei dataa

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt